Residency · Orange, CA
Sponsored by University of California (Irvine)
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024.
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 226 citations · Harry Herr
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study.
The Lancet. Oncology · 2021 · 479 citations · Edward Uchio
The current landscape of single-port robotic surgery in urology.
Nature reviews. Urology · 2026 · 29 citations · David Lee
Updates to Surgical Treatment of Female Stress Urinary Incontinence (SUI): AUA/SUFU Guideline (2023).
The Journal of urology · 2023 · 92 citations · Kathleen Kobashi
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.
Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 259 citations · Harry Herr
Irreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE Trial.
European urology · 2026 · 17 citations · Edward Uchio
Surgical Management of Kidney and Ureteral Stones: AUA Guideline (2026) Part I: Evaluation and Treatment of Patients With Kidney and/or Ureteral Stones.
The Journal of urology · 2026 · 15 citations · Ryan Hsi
Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial Results.
The Journal of urology · 2023 · 45 citations · Edward Uchio, Greg Gin